← Back to Search

Diagnostic Tool

Core Stethoscope vs. Ultrasound for Endotracheal Intubation

N/A
Waitlist Available
Led By Ban Tsui, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Surgery requiring an ETT
Any patients under the age of 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during assessment with point of care ultrasound (10min)
Awards & highlights

Study Summary

This trial found that the Core stethoscope was not able to distinguish between tracheal and bronchial intubation with auscultation.

Who is the study for?
This trial is for patients of any age needing an endotracheal tube (ETT) for surgery. They must consent or have parental consent if under 18. It's not for those with major heart problems, significant lung disease, or anticipated difficult airway.Check my eligibility
What is being tested?
The study compares the accuracy of a new Core stethoscope and point-of-care ultrasound in confirming correct ETT placement during surgery to avoid complications like respiratory failure.See study design
What are the potential side effects?
There are no direct side effects from using the Core stethoscope or ultrasound as they are non-invasive diagnostic tools; however, there may be indirect risks if these methods fail to accurately detect ETT misplacement.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need surgery that requires being put on a breathing machine.
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during assessment with point of care ultrasound (10min)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during assessment with point of care ultrasound (10min) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Localization of endotracheal tube placement by the presence/absence of breath sounds detected by Core-Eko augmented stethoscope
Localization of endotracheal tube placement by the presence/absence of lung pleural linings movement by ultrasound

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment2 Interventions
All participants will have placement of ETT confirmed using both Core stethoscope and point-of-care ultrasound
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Point of care ultrasound
2022
N/A
~240

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,379 Previous Clinical Trials
17,333,293 Total Patients Enrolled
Ban Tsui, MDPrincipal InvestigatorStanford University
4 Previous Clinical Trials
133 Total Patients Enrolled

Media Library

Eko CORE Stethoscope (Diagnostic Tool) Clinical Trial Eligibility Overview. Trial Name: NCT04797520 — N/A
Endotracheal Intubation Research Study Groups: Treatment
Endotracheal Intubation Clinical Trial 2023: Eko CORE Stethoscope Highlights & Side Effects. Trial Name: NCT04797520 — N/A
Eko CORE Stethoscope (Diagnostic Tool) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04797520 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor still allow for participation?

"As per what is stated on the clinicaltrials.gov website, this particular trial has ceased its recruitment efforts since January 18th 2022. However, there are still 13 other trials currently searching for participants to join them."

Answered by AI
Recent research and studies
~50 spots leftby Aug 2024